This inventor holds 1 USPTO granted patent. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Michael F Jung: Innovator in Oligonucleotide Synthesis
Introduction
Michael F Jung, an esteemed inventor based in Los Angeles, CA, has made significant contributions to the field of oligonucleotide synthesis. His innovative work in developing processes and reagents for improving the synthesis and purification of oligonucleotides showcases his expertise and dedication to advancing scientific research.
Latest Patents
Michael F Jung holds a notable patent titled "Process for Desilylation of Oligonucleotides." This invention pertains to the methodologies and reagents used in oligonucleotide synthesis and purification. Key aspects of the patent involve the use of specific compounds to activate phosphoramidites in oligonucleotide synthesis. Additionally, it addresses the preparation of oligonucleotides via the phosphoramidite method using innovative activators. The patent also introduces sulfur-transfer agents, particularly a 3-amino-1,2,4-dithiazolidine-5-one, which play a crucial role in producing phosphorothioates and scavenging harmful byproducts like acrylonitrile during synthesis. Furthermore, methods for oligonucleotide purification through chromatographic techniques, such as high-performance liquid chromatography, are detailed within the patent.
Career Highlights
Michael F Jung currently works at Alnylam Pharmaceuticals, Inc., where he continues to push the boundaries of research in pharmaceutical innovations. His expertise in the biochemical processes of oligonucleotides positions him as a valuable asset to the company and the broader scientific community.
Collaborations
Throughout his career, Michael has collaborated with prominent figures such as Muthiah Manoharan and Kallanthottathil G Rajeev. These partnerships have fostered a collaborative research environment, leading to advancements in therapeutic applications of oligonucleotides.
Conclusion
With a steadfast commitment to innovation, Michael F Jung's contributions to oligonucleotide synthesis have paved the way for future advancements in biomedical research. His pioneering work not only enhances the scientific understanding of oligonucleotide functionalities but also holds the potential to revolutionize therapeutic strategies in treating various diseases.